About us Pricing ContactSubscribe

J

John Sahl Andersen

The University of Texas Health Science Center at San AntonioORCID https://orcid.org/0000-0001-7235-4359

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Journal of Clinical Oncology19975,865 citations

John Sahl Andersen · Scinovex